Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Education RFPsEducation Bids and Bidding Guide
More education bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Vaccine Development

U.S. Department Of Defense·Maryland

Vaccine Development

Closes 5/6/2026$500k – $2MSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The United States Department of the Naval Medical Research Command (NMRC) is proposing to enter into a contract with Wake Forest University School of Medicine for vaccine development. The requirement includes the development of a Tree Shrew Primary Infection Model and analysis of Immune Response and Identification of Biomarkers of Disease Severity in a Tree Shrew-Model. The contract will be procured under the guidelines of FAR Part 12 Commercial Items. • The contract is for authorized approved vendors to perform services for brand name equipment. • The NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems for Award Management (SAM). • The vendor must have a Unique Entity Identification Number (UEI) to be eligible to receive an award from this Acquisition Office.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Nataki Johnson

[email protected]

Key dates

Opened
5/1/2026
Closes
5/6/2026

Last updated

Details

Type
Sole Source
Industry
Education
NAICS
611310
Solicitation №
N3239826Q7221

Budget estimate

$500,000 – $2,000,000

The budget for this contract is not specified in the document. However, based on the scope of work, which includes the development of a Tree Shrew Primary Infection Model and analysis of Immune Response, the budget could be in the range of $500,000 to $2 million. This estimate is based on the assumption that the contract will involve significant research and development costs, including personnel, equipment, and materials. The actual budget could be higher or lower, depending on the specific requirements of the contract and the qualifications of the contractor.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Centers for Disease Control-GHC·United States of America

Top match · 71%

Capacity Building for Global, Regional, and National Immunization Programs

Closes 3/13/2027Opened 8/14/2026

U.S. National Institutes of Health·United States of America

71% match

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 4/9/2026

U.S. Centers for Disease Control-GHC·United States of America

70% match

Capacity Building for National Immunization Programs in the Eastern Mediterranean Region

Closes 3/13/2027Opened 8/31/2026

U.S. Department Of Defense·Maryland

68% match

Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination

Closes 11/6/2026Opened 9/24/2026

U.S. National Institutes of Health·United States of America

68% match

Technology Development Program

Closes 2/4/2028Opened 9/16/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

67% match

Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network

Closes 1/29/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

67% match

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

U.S. Department Of Agriculture·Minnesota

66% match

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Closes 11/10/2026Opened 10/1/2026

U.S. Department Of Agriculture·Iowa

66% match

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Closes 11/10/2026Opened 10/1/2026

U.S. Department Of Health And Human Services·United States of America

66% match

2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases

Closes 12/8/2026Opened 10/9/2026

U.S. National Institutes of Health·United States of America

66% match

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Closes 11/5/2028Opened 12/30/2024

U.S. Department Of Defense·Maryland

65% match

Request for Information – Prophylactic Platform for Medical Countermeasures

Closes 11/18/2026Opened 10/19/2026

U.S. Department Of Health And Human Services·Maryland

65% match

Notice of Intent to Sole Source: Peer-to-peer Immunization Training and Curriculum Deployment

Closes 11/6/2026Opened 10/23/2026

U.S. Centers for Disease Control - NCHHSTP·United States of America

65% match

National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers

Closes 6/30/2027Opened 7/9/2026

U.S. National Institutes of Health·United States of America

65% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. Department Of Health And Human Services·District of Columbia

65% match

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Closes 11/20/2026Opened 9/11/2026

U.S. Department Of Health And Human Services·District of Columbia

65% match

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Closes 11/20/2026Opened 9/11/2026

U.S. Centers for Disease Control-GHC·United States of America

64% match

Informing global polio eradication efforts through innovative modeling approaches

Closes 3/13/2027Opened 8/31/2026

U.S. Food and Drug Administration·United States of America

64% match

Animal and Veterinary Innovation Centers (U18)

Closes 5/12/2028Opened 6/20/2024

U.S. Centers for Disease Control - NCHHSTP·United States of America

64% match

Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Closes 6/22/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

64% match

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. Department Of Health And Human Services·Georgia

64% match

Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance - SPEED 2027-2032

Closes 11/8/2026Opened 10/8/2026

U.S. Department Of Health And Human Services·United States of America

64% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. Department Of Defense·Maryland

64% match

BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB

Closes 12/31/2030Opened 3/24/2026

U.S. National Institutes of Health·United States of America

64% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026